Skip to main content

Table 4 Comparison of treatment outcome between Bedouins and Jews

From: Clinical and epidemiologic characteristics of non Hodgkin’s lymphoma in Bedouins in the south of Israel

 

Bedouins

Jews

p value

 

No.

%

No.

%

 

Remission

     
 

Yes

25

65.8

32

80

 
 

No

10

26.3

5

12.5

 
 

Partial

3

7.9

3

7.5

0.290

Relapse

     
 

Yes

12

34.3

7

18.9

 
 

No

23

65.7

30

81.1

0.139

Mean overall survival (months)

70 (95% CI: 43–96)

168 (95% CI: 144–192)

<0.001

Mean disease-free survival (months)

57 (95% CI: 32–83)

145 (95% CI: 116–175)

<0.001

DLBCL patients

   

Mean overall survival (months)

88 (95% CI:54–122)

153 (95% CI:118–188)

0.054

Mean disease-free survival (months)

75 (95% CI:41–108)

136 (95% CI:98–174)

0.046